Luxturna gene therapy has been successfully used to improve vision in a six-year-old child with Leber's Congenital Amaurosis.
Claims
Luxturna gene therapy has been successfully used to improve vision in a six-year-old child with Leber's Congenital Amaurosis.
Parent: HealthcareEntity: Gene TherapySub-entity: LuxturnaImpact: positiveDate: Apr 23, 2026Target: Luxturna gene therapy's effectiveness in treating Leber's Congenital Amaurosis in young children
Source posts
A six-year-old girl's vision has improved significantly after a one-off gene therapy treatment. This is the first time this therapy has been used on such a young child for this condition.
#GeneTherapy, #Luxturna, #LCA, #Stevenage, #EyeHealth
https://newsletter.tf/stevenage-girl-vision-gene-therapy-luxturna-lca/
0 boosts · 0 favs · 0 replies · Apr 23, 2026
#genetherapy#luxturna#lca#stevenage#eyehealth
Six-Year-Old's Vision Altered by Gene Intervention
Six-year-old Saffie Sandford from Stevenage sees better after Luxturna gene therapy for Leber's Congenital Amaurosis at Great Ormond Street Hospital.
#GeneTherapy, #Luxturna, #LCA, #Stevenage, #EyeHealth
https://newsletter.tf/stevenage-girl-vision-gene-therapy-luxturna-lca/
0 boosts · 0 favs · 0 replies · Apr 23, 2026
#genetherapy#luxturna#lca#stevenage#eyehealth